NovaVive Inc. - Canine

NovaVive Inc. - Canine NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

Bama Belle sadly lost her battle with cancer. However, we were glad to be able to offer support for almost 10 months aft...
08/12/2025

Bama Belle sadly lost her battle with cancer. However, we were glad to be able to offer support for almost 10 months after she started our therapy.

As her guardian says, “I believe we were blessed with more time because of you and Immunocidin. I am eternally grateful for everything you provided during this difficult period.”

Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being...
08/07/2025

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

It is safe to use in all veterinary clinics.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

08/07/2025

Zoey, a 9-year-old German Shepherd from Albuquerque, NM, was diagnosed with liposarcoma. She passed away in early December, about 211 weeks after starting Immunocidin therapy.

"Zoey passed away from a suspected mass on her spleen that ruptured. She was a very sweet girl who always watched over everyone, especially her brother, Copper. She was also deeply loved and respected by her other sibling, Peyton. Zoey had a nurturing spirit—she checked on my dad every night when he stayed with us after surgery. After we lost Copper, we worried Zoey might be sad without him, so we rescued a puppy. Zoey became a wonderful mother to her, caring for her as if she were her own. We're so grateful we had more time with her and that she got to experience being a mom."

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog. The product is appro...
07/31/2025

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog.

The product is approved in the USA and Canada for treating canine mammary cancer and research is ongoing in other tumor types.

Visit NovaVive.ca/products to learn more

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further...
07/24/2025

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further research has demonstrated that it can also be safely administered by IV injection.

Immunocidin is approved by regulators in the USA and Canada. Research is ongoing with this product in various tumor types using different administration methods.

Visit NovaVive.ca/products for more information.

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.Nov...
07/17/2025

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.

NovaVive continues to explore other cancers for which Immunocidin may be effective. One of these is osteosarcoma (bone cancer).

Learn more about Immunocidin research at http://novavive.ca/canine-research.

Cody sadly lost his battle with cancer. However, we were glad to be able to offer support for 16-and-a-half months after...
07/08/2025

Cody sadly lost his battle with cancer. However, we were glad to be able to offer support for 16-and-a-half months after he started our therapy.

Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including osteosarcoma.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Immunocidin is our immunotherapy for canine cancer. Visit NovaVive.ca/products to learn more.
07/03/2025

Immunocidin is our immunotherapy for canine cancer. Visit NovaVive.ca/products to learn more.

Seeing our beloved pets reach the end of their lives is difficult. Often, there are no further treatment options and we ...
07/02/2025

Seeing our beloved pets reach the end of their lives is difficult. Often, there are no further treatment options and we must face losing them.

Immunocidin immunotherapy has been used as a palliative treatment to help pets stay comfortable. Ask your veterinarian about Immunocidin or visit NovaVive.ca/products for more information.

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being...
06/18/2025

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

It is safe to use in all veterinary clinics.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Address

Napanee, ON

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NovaVive Inc. - Canine:

Share